Transplant Dysfunction Clinical Trial
Official title:
Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients - a Pilot Study.
The aim is to investigate the safety and potential effect of Low-energy Shockwave Therapy
(ESWT) on the transplanted kidney. The treatment consist of ESWT two times a week for three
weeks, six treatments in total.
The hypothesis is that ESWT with improve the renal function, by reducing proteinuria (in a
24-hour urine collection test) and improving renal clearance of 51Cr-EDTA.
The safety of ESWT on the renal allograft will be assessed during and after treatments.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
| Recruiting |
NCT03855722 -
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)
|
N/A | |
| Completed |
NCT03446196 -
Hemodynamic Optimization During Single Kidney Transplantation With MostcareUP
|
N/A | |
| Completed |
NCT04019353 -
Cf-DNA Assay During Treatment of Acute Rejection
|
||
| Withdrawn |
NCT03314376 -
Prehabilitation in Patients on a Waiting List for a Transplant
|
N/A | |
| Completed |
NCT04643665 -
Prediction of Pulmonary Graft Dysfunction After Double-lung Transplantation (PGD3-AI Study)
|
||
| Not yet recruiting |
NCT05951231 -
Liver Transplantation After ex Vivo Liver Perfusion
|
N/A | |
| Completed |
NCT03123796 -
Effects of Proton Pump Inhibitors on Kidney Transplant Recipients
|
N/A |